会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Antitumor and immunosuppressive 4-carbamoylimidazolium-5-olate
derivatives
    • 抗肿瘤剂和免疫抑制剂4-氨基甲酰基咪唑鎓-5-醇酸酯衍生物
    • US4410696A
    • 1983-10-18
    • US305347
    • 1981-09-24
    • Toshio AtsumiTetsutaro SanjikiTakao Kiyohara
    • Toshio AtsumiTetsutaro SanjikiTakao Kiyohara
    • C07D233/90
    • C07D233/90
    • There are provided compounds of the formula: ##STR1## wherein R is a mono-substituted benzoyl group wherein the substituent is a phenyl group, an alkanoyl group, a formyl group, a halogeno-alkyl group, an aralkyloxy group, a phenoxy group, an alkoxycarbonyl group, an aralkyloxycarbonyl group, an alkanoyloxy group, a benzoyl group, a carboxyl group, a hydroxy group, a group of the formula: ##STR2## (wherein X.sub.1 and X.sub.2 are a hydrogen atom or a lower alkyl group), an aralkyloxycarbonylamino group, a lower alkoxycarbonylamino group, a carboxyamino group or a carbamoyl group; a cinnamoyl group which may be substituted at the .alpha. position or the phenyl ring with an alkyl group, an alkoxy group, an aryl group, a nitro group, a methylenedioxy group, a formyl group, a halogeno-alkyl group, a halogen atom, a hydroxy group, a carboxyl group, an amino group or a cyano group; or a benzoyl group substituted with from two to five of the same or different substituents selected from the group consisting of alkyl groups, alkoxy groups, aralkyloxy groups, nitro group, halogen atoms, hydroxy group, alkanoyloxy groups, formyl group, carboxyl group, alkylthio groups, alkylsulfonyl groups, groups of the formula: ##STR3## (wherein X.sub.1 and X.sub.2 are a hydrogen atom or a lower alkyl group), sulfo group and sulfamoyl group; or its non-toxic salt, and a process for producing them. The compounds are useful as antitumor agents and immunosuppressants.
    • 提供下式的化合物:其中R是单取代的苯甲酰基,其中取代基是苯基,烷酰基,甲酰基,卤代烷基,芳烷氧基,苯氧基, 烷氧基羰基,芳烷氧基羰基,烷酰氧基,苯甲酰基,羧基,羟基,下式的基团:其中X 1和X 2是氢原子或低级烷基, 芳烷氧基羰基氨基,低级烷氧基羰基氨基,羧基氨基或氨基甲酰基; 可以在α位置取代的肉桂酰基或具有烷基,烷氧基,芳基,硝基,亚甲二氧基,甲酰基,卤代烷基,卤素原子, 羟基,羧基,氨基或氰基; 或被两个至五个相同或不同的取代基取代的苯甲酰基,所述取代基选自烷基,烷氧基,芳烷氧基,硝基,卤素原子,羟基,烷酰氧基,甲酰基,羧基,烷硫基 基团,烷基磺酰基,下式的基团:其中X 1和X 2是氢原子或低级烷基,磺基和氨磺酰基; 或其无毒盐,以及其生产方法。 该化合物可用作抗肿瘤剂和免疫抑制剂。
    • 7. 发明授权
    • Analgesic compositions containing 2-cyanoalkylbenzomorphan derivatives
and salts thereof
    • 含有2-氰基烷基苯并喃衍生物及其盐的止痛组合物
    • US3962446A
    • 1976-06-08
    • US523412
    • 1974-11-13
    • Toshio AtsumiKenji KobayashiYoshiaki TakebayashiHisao Yamamoto
    • Toshio AtsumiKenji KobayashiYoshiaki TakebayashiHisao Yamamoto
    • A61K31/395A61K31/485
    • A61K31/395
    • An analgesic composition comprising an analgesically effective amount of at least one 6,7-benzomorphan derivative of the formula: ##SPC1##Wherein R is a hydrogen atom, a hydroxyl group, a C.sup.1 - C.sup.3 alkoxy group or a C.sup.1 - C.sup.8 alkanoyloxy group; R.sub.1 is a hydrogen atom, a C.sup.1 - C.sup.5 alkyl group, a phenyl group, a halophenyl group, an alkylphenyl group wherein the alkyl moiety has 1 to 3 carbon atoms, an alkoxyphenyl group wherein the alkoxy moiety has 1 to 3 carbon atoms, a trifluoromethylphenyl group, an alkylthiophenyl group wherein the alkylthio moiety has 1 to 3 carbon atoms or a group of the formula (C.sub.m H.sub.2m.sub.-p.sub.+1) - (R.sub.9).sub.p wherein m is an integer of 1 - 6, p is an integer of 1 - 2 and R.sub.9 is a C.sup.1 - C.sup.3 alkoxy group; R.sub. 2 is a hydrogen atom or a C.sup.1 - C.sup.3 alkyl group; R.sub.3 is a hydrogen atom, a C.sup.1 - C.sup.3 alkyl group, a phenyl group or an alkoxyphenyl group wherein the alkoxy moiety has 1 to 3 carbon atoms; R.sub.4 is a hydrogen atom or a hydroxyl group, or R.sub.3 and R.sub.4 may form a C.sup.1 - C.sup.3 alkylidene group or a carbonyl group together with a carbon atom to which these substituents are bonded; R.sub.5 is a hydrogen atom or C.sup.1 - C.sup.3 alkyl group; R.sub.6 is a hydrogen atom or a methyl group; R.sub.7 and R.sub.8 are independently a hydrogen atom or a C.sup.1 - C.sup.2 alkyl group; and n is an integer of 0 - 2; or an acid addition salt thereof, and a pharmaceutically acceptable carrier or diluent, is disclosed.
    • 一种止痛组合物,其包含镇痛有效量的至少一种下式的6,7-苯并吗啉衍生物:WHEREIN R是氢原子,羟基,C1-C3烷氧基或C1-C8烷酰氧基; R1为氢原子,C1-C5烷基,苯基,卤代苯基,烷基部分为碳原子数1〜3的烷基苯基,烷氧基部分为碳原子数1〜3的烷氧基苯基, 三氟甲基苯基,其中烷硫基部分具有1至3个碳原子的烷硫基苯基或式(CmH2m-p + 1) - (R9)p的基团,其中m是1-6的整数,p是整数1 - 2和R9是C1-C3烷氧基; R 2是氢原子或C 1 -C 3烷基; R3是氢原子,C1-C3烷基,苯基或烷氧基苯基,其中烷氧基部分具有1至3个碳原子; R4是氢原子或羟基,或者R3和R4可以与这些取代基结合的碳原子一起形成C1-C3亚烷基或羰基; R5是氢原子或C1-C3烷基; R6是氢原子或甲基; R 7和R 8独立地为氢原子或C 1 -C 2烷基; n为0-2的整数; 或其酸加成盐,以及药学上可接受的载体或稀释剂。
    • 9. 发明授权
    • 4-Carbamoylimidazolium-5-olate derivatives
    • 4-氨基甲酰基咪唑鎓-5-醇酸酯衍生物
    • US4464531A
    • 1984-08-07
    • US366423
    • 1982-04-07
    • Toshio AtsumiYuzo TarumiTetsutaro SanjikiYoshiaki TakebayashiNoboru Yoshida
    • Toshio AtsumiYuzo TarumiTetsutaro SanjikiYoshiaki TakebayashiNoboru Yoshida
    • C07H17/02A61K31/70
    • C07H17/02
    • There are provided compounds of the formula: ##STR1## wherein either R.sub.1 or R.sub.2 is a hydrogen atom, a hydroxy group, an acyloxy group, a phthalimido group or an acetamido group and the other is a hydrogen atom; either R.sub.3 or R.sub.4 is a hydroxy group or an acyloxy group and the other is a hydrogen atom; either R.sub.5 or R.sub.6 is a hydroxy group or an acyloxy group and the other is a hydrogen atom; either R.sub.7 or R.sub.8 is a hydrogen atom, a methyl group, a hydroxymethyl group, an acyloxymethyl group, an alkoxycarbonyl group, a group of the formula: ##STR2## (wherein X.sub.1 and X.sub.2 are a hydrogen atom or a lower alkyl group), or a carboxyl group and the other is a hydrogen atom; either R.sub.11 or R.sub.12 is a hydrogen atom, a hydroxy group or an acyloxy group and the other is a hydrogen atom; either R.sub.13 or R.sub.14 is a hydroxy group or an acyloxy group and the other is a hydrogen atom; either R.sub.15 or R.sub.16 is a methyl group, a hydroxymethyl group or an acyloxymethyl group and the other is a hydrogen atom; and a process for producing them. These compounds are useful as antitumor agents.
    • 提供下式的化合物:其中R 1或R 2为氢原子,羟基,酰氧基,苯二甲酰亚氨基或乙酰氨基,其中R 1或R 2为氢原子, 另一个是氢原子; R3或R4是羟基或酰氧基,另一个是氢原子; R5或R6是羟基或酰氧基,另一个是氢原子; R7或R8是氢原子,甲基,羟甲基,酰氧基甲基,烷氧基羰基,下式的基团:其中X1和X2是氢原子或低级烷基, 或羧基,另一个是氢原子; R 11或R 12是氢原子,羟基或酰氧基,另一个是氢原子; R13或R14是羟基或酰氧基,另一个是氢原子; R 15或R 16是甲基,羟甲基或酰氧基甲基,另一个是氢原子; 以及生产它们的过程。 这些化合物可用作抗肿瘤剂。